ORKA Q1 2021 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$17,000

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-3.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$69M

Total Liabilities

$3M

Stockholders' Equity

$66M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$17,000	-$25,000	+32.0%
Operating Income	-$4M	-$1M	-206.1%
Net Income	-$4M	-$1M	-210.6%